Lausanne, Switzerland and Irvine, California (ots/PRNewswire) - IsoTis OrthoBiologics (SWX/Euronext: ISON; TSX: ISO) today reported a 16% increase in orthobiologics sales of US$12.9 million for the first six months of fiscal 2004, compared to pro-forma orthobiologics sales of US$11.1 million for the first six months of 2003. Sales for the second quarter 2004 were ...
Cambridge, England, Montreal, Canada. Washington D.c. and Lille, France (ots/PRNewswire) - - Initial European Roll out Planned for 2005 - Strategic Alliance to Include Development of Filters for Viruses - MacoPharma to Market and Distribute the Products - Financial Arrangement Based on Revenue ...
Basel, Switzerland (ots/PRNewswire) - Novartis Pharma AG announced today that the Committee for Medicinal Products for Human Use (CHMP), adopted a positive opinion recommending that the European Commission (EC) grant a Marketing Authorisation for Emselex(R) (darifenacin hydrobromide), 7.5mg and 15mg, for the treatment of overactive bladder (OAB) in all 25 European ...
DEERFIELD, Ill., and CONCORD, Calif. (ots) - Subsidiaries of Baxter International Inc. (NYSE: BAX) and Cerus Corporation (NASDAQ: CERS) today announced that they have entered into a definitive agreement with BioOne Corporation for commercialization of the INTERCEPT Blood System for platelets in parts of Asia. The ...
Montreal (ots/PRNewswire) - ProMetic Life Sciences Inc. (TSX: PLI) announced today that the Company will host a conference call and live webcast on Wednesday, August 4, 2004 at 11:00 a.m. (EST) to discuss financial results and business highlights for the second quarter ended June 30, 2004. To access the ...
Geneva (ots) - The Unilabs laboratory in Lugano (Tessin) has signed an agreement with two hospital establishments located in the Lugano area. These hospitals comprise a total of 150 beds and accommodate around 6,500 hospitalized patients and 32,000 outpatients per year. The contract, which takes effect immediately, relates to an estimated annual turnover of CHF 1.5 million and a minimum period of until December 31, ...
Vienna, Austria (ots) - AOP Orphan Pharmaceuticals, manufacturer and product developer of Thromboreductin®, announces that it has achieved its intermediate goal to make Thromboreductin® available in the European Union by means of an ambitious GCP compliant clinical trial programme. Thromboreductin is the first Anagrelide containing medicinal product approved ...
Lausanne (ots) - Orange Communications SA, Lausanne, is to support The Body Shop's "Stop domestic violence" campaign. For every used, but still fully functional, mobile telephone handed into any of the 37 Orange points of sale, Orange will donate CHF 10 in favour of women's shelters in Switzerland and Liechtenstein. Used mobile phones can also be handed into any of ...
BANGKOK, Thailand, July 12 (ots/PRNewswire) - - Healthcare professionals and patients map out steps towards optimal use of FUZEON(R) Despite the clear benefits for patients and the high rates of resistance in the west, new research has shown that currently only 1 out of 5 eligible patients is benefiting from the latest HIV breakthrough, FUZEON(R) ...
EDMONTON, Canada, July 7 (ots/PRNewswire) - Isotechnika Inc. today announced that the Company has received permission from the Food and Drug Administration of the United States for the commencement of a Phase Ib human clinical trial for TAFA-93. TAFA-93 is a novel prodrug of the mTOR inhibitor rapamycin designed to reduce the unfavourable pharmacokinetics ...
EDMONTON, Canada, July 6 (ots/PRNewswire) - Isotechnika Inc. (TSX:ISA) announced today the completion of the single ascending dose trial for the Company's lead immunosuppressive drug candidate, ISA247. The SAD trial was conducted in healthy volunteers using the trans-ISA247 formulation to assess the appropriate dosage of the enhanced composition of the drug. The data confirms that the trans formulation of ...
BASEL, Switzerland, July 2 (ots/PRNewswire) - Novartis Pharma AG yesterday submitted its application for the European approval of Xolair(R) (omalizumab), a novel therapy which targets a root cause of allergic disease and offers an entirely new approach to the treatment of allergic asthma. The file, submitted to ...
DUBLIN, California, July 1 (ots/PRNewswire) -- - EuroGen Subsidiary Seeks Centralized Review for Pancreatic Cancer Treatment SuperGen, Inc. (Nasdaq: SUPG) announced today that a Marketing Authorization Application (MAA) seeking approval of Orathecin(TM) (rubitecan) Capsules has been submitted to the European Agency for the Evaluation of Medicinal Products (EMEA). Orathecin is the Company's investigational oral ...
Geneva (ots) - The hospitals of the Vaud Riviera (Montreux Hospital and Hôpital du Samaritain in Vevey) have just extended their partnership with Unilabs until 2011 by adding a new partner, the Hôpital de la Providence in Vevey. The signature of this agreement confirms the excellent collaboration started in June 2000 with the Hôpital Riviera. The contract ...
Geneva (ots) - Biocheckup tests will allow early detection of signs of illness and permit evaluation of the risk factors for diseases such as diabetes, cancer or cardiovascular disease Most people are concerned by the state of their health and would like to know their predisposition to different pathologies before they become established (e.g. diabetes, cancer, ...
Nat. Council of State Boards Nursing
CHICAGO, IL (ots) - The National Council of State Boards of Nursing (NCSBN) at www.ncsbn.org has selected the first three countries for purposes of offering the NCLEX examinations abroad for domestic nurse licensure purposes. NCSBN's Board of Directors affirmed the decision at its May meeting upon recommendation from the NCSBN Examination Committee. NCLEX testing is expected to begin January 2005 in Seoul, South Korea; ...
Geneva (ots) - Novo Nordisk Switzerland announced today that Levemir® (insulin detemir), a novel, predictable basal insulin analogue with a unique mechanism of prolonging action (scientifically known as protraction), is available for people with type 1 and type 2 diabetes in Switzerland today. The Swiss launch is just the beginning of an exciting global roll-out of ...
Leeds (ots) - The completely updated version of the classic text captures the latest significant research findings in a reader-friendly format. Designed to more effectively meet the needs of students, this edition continues to make learning easy and enjoyable with chapter overviews, detailed figures, key terms, study questions, references, and an updated glossary ...
Jacobson Resonance Enterprises
BOYNTON BEACH, FL (ots) - Jacobson Resonance Enterprises, Inc. (OTC BB: JRSE) announced today that the United States Food and Drug Administration has granted an allowance to implement our state-of-the-art Jacobson Resonance Technology in the multi-billion dollar leisure/spa arena for relaxation purposes. ...
Hoofdorp, The Netherlands (ots) - To help people improve their lifestyle and encourage healthy living and eating habits, Omron Healthcare Europe has launched "Enjoy your Life", a new section on its website. The new section offers people the chance to learn about how to improve their diet in order to maintain or improve their health. "At Omron, we believe that nutrition is highly important for healthy ...
London (ots) - William Ransom & Son plc, the natural healthcare company, announced today a pre-tax profit before amortisation of goodwill of £0.055m in its interim results to 30 September 2003 (pre-tax loss of £0.095m after amortisation of goodwill). The Directors have declared a dividend of 0.50p. In summary: · Turnover declined by 1.6% to £6.731 ...
Wiesbaden, Germany (ots) - Ministers of Health, Finance and Planning from 40 developing countries will come together with development partners at WHO headquarters from 29 to 30 October to address the need to significantly increase investments in health. This is the first time that the World Health Organization (WHO) has hosted a meeting so widely attended by ...
London (ots) - William Ransom, the natural healthcare company, today confirmed that it is considering the sale of its valuable Hitchin town centre site for residential development. A reorganisation would produce operational savings as pharmaceutical manufacture is transferred to the company's Witham site. Cash ...
London (ots) - William Ransom, the natural healthcare company, today strengthens its brand development and corporate finance expertise by the appointment of two highly-experienced non-executive directors. Jacqueline Paterson, Head of Beauty and Lingerie at Marks & Spencer, and William Nabarro, a senior corporate financier, join the Board with effect from ...
Canton, MA (ots) - The Journal of the American Medical Directors Association reported today on the results of a one-year study on soft hip protectors in a nursing home. In the study, residents who were at risk of hip fractures and asked to wear HipSaver® hip protectors did so 93% of the time. This contrasts ...
London, UK (ots) - Antisoma plc, (LSE: ASM; Nasdaq Europe: ASOM) the biopharmaceutical company specialising in novel anti-cancer drugs, today announces that it has in-licensed a programme of telomerase inhibitors from Cancer Research Technology Ltd, the technology transfer arm of the charity Cancer Research UK. This programme was developed by Professor Stephen ...
Nat. Council of State Boards Nursing
CHICAGO, IL (ots) - The National Council of State Boards of Nursing (NCSBN) met August 5-8, in Alexandria, Virginia, to consider key organizational business. Donna Dorsey, NCSBN President and Executive Director of the Maryland Board of Nursing, presided at the meeting in which 55 of the 61 member boards participated. Significant actions included: - Election of new NCSBN area directors and ...
Madrid (ots) - New data from the VIM study presented today at the annual Congress of the European Society of Ophthalmology (SOE) demonstrate that Visudyne® therapy benefited patients with smaller base line lesions* in minimally classic "wet" AMD, a form of AMD previously considered untreatable.1 Visudyne is the ...
See picture: www.newsaktuell.ch/f/story.htx?nr=100462691 Geneva (ots) - With an increase of around 200% in the last 3 weeks, sales of the "Mini Anti-Germ Traveller Kit" produced by Geneva-based company Swissclean SA have shown remarkable growth. This growth has coincided with the SARS (Severe Acute Respiratory Syndrome) epidemic. The traveller kit (17cm x 14cm ...
CANTON, MA (ots) - A new study published in The Journal of the American Medical Association reports that a hard shell hip protector was ineffective in preventing hip fractures in older people. The study, conducted in Amsterdam, on 561 older persons concludes that moderate daytime and poor nighttime compliance were major factors in the negative outcome. The study ...